GO
Loading...

Cramer’s Pharma Play

Monday, 19 Sep 2011 | 6:59 PM ET
In Good Health: Sanofi
Sanofi announced it won a patent litigation case over its eloxation cancer drug, with Christopher Viehbacher, Sanofi CEO, and Mad Money host Jim Cramer.

If you want to play it safe in this market, than Paris-based drug company Sanofi-Aventis is for you, Cramer said Monday.

The stock got pounded earlier in the day, but CEO Chris Viehbacher told the “Mad Money” host that’s because people aren’t paying attention to the fundamentals right now.

“Nothing has fundamentally changed with the company,” he said. “People are just worried about the overall European context.”

Cramer agreed. “This is exactly the kind of stock you should buy the next time Europe drags it down,” he said, “because it bounces right back.”

To see Cramer’s full interview with CEO Chris Viehbacher, watch the video!

Call Cramer: 1-800-743-CNBC

When this story was published, Cramer’s charitable trust owned Sanofi-Aventis.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
SNI
---

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.